Robert Paull

Board Member Co-Founder and Venture Partner, Lux Capital
Mr. Paull has served as a member of our board of directors since July 2009. Mr. Paull was a co-founder of, and since 2014 has been a Venture Partner at, Lux Capital Management, or Lux Capital, where he focuses on healthcare ventures. In addition, Mr. Paull served as our founding Chief Executive Officer, President and Treasurer from July 2009 to June 2012. Mr. Paull also served as founding Chief Executive Officer of Genocea Biosciences Inc., a vaccine discovery and development company, from August 2006 to February 2009, and was the co-founder of Lux Research, Inc., an emerging technology market research and consulting firm, which was founded in January 2004. Most recently, Mr. Paull served as Chief Executive Officer of Mahana Therapeutics, Inc., a digital therapeutics company, from January 2018 to December 2020. Mr. Paull holds a B.S. in Architecture from the University of Virginia.